_____________
The joint committee for Administrative Rules reported and recommended:
Relating to operator’s licenses and identification cards.
Modifications requested.
Ayes: 10 – Senator Nass; Representative Neylon; Senators Bradley, Tomczyk, Roys and Ratcliff; Representatives Peterson, Spiros, Snodgrass and Arney.
Noes: 0 – None.
STEVE NASS
Senate Chairperson
_____________
The committee on Financial Institutions and Sporting Heritage reported and recommended:
Relating to correcting out-of-date cross-references, repealing obsolete provisions, modifying the structure of existing rules to conform to current drafting practices, and revising the definition of “member business loan” to conform to federal law.
No action taken on February 25, 2025.
Referred to the joint committee for review of Administrative Rules, February 25, 2025.
Relating to eliminating obsolete provisions, correcting cross-references, eliminating rules that are redundant with statutes, correcting errors, and modifying the structure of existing rules in nonsubstantive ways.
No action taken on February 25, 2025.
Referred to the joint committee for review of Administrative Rules, February 25, 2025.
Relating to wildlife damage and abatement.
No action taken on February 25, 2025.
Referred to the joint committee for review of Administrative Rules, February 25, 2025.
Relating to the deer management assistance program.
No action taken on February 25, 2025.
Referred to the joint committee for review of Administrative Rules, February 25, 2025.
Relating to Lake Superior cisco and lake trout regulations and affecting small business.
No action taken on February 25, 2025.
Referred to the joint committee for review of Administrative Rules, February 25, 2025.
ROB STAFSHOLT
Chairperson
_____________
The committee on Mental Health, Substance Abuse Prevention, Children and Families reported and recommended:
Relating to excluding [18 F]FP-CIT.
No action taken on February 25, 2025.
Referred to the joint committee for review of Administrative Rules, February 25, 2025.
Relating to scheduling Mesocarb.
No action taken on February 25, 2025.
Referred to the joint committee for review of Administrative Rules, February 25, 2025.
Relating to national provider identifier requirement.
No action taken on February 25, 2025.
Referred to the joint committee for review of Administrative Rules, February 25, 2025.
Relating to scheduling Methiopropamine.
No action taken on February 25, 2025.
Referred to the joint committee for review of Administrative Rules, February 25, 2025.
Relating to excluding Fenfluramine.
No action taken on February 25, 2025.
Referred to the joint committee for review of Administrative Rules, February 25, 2025.
Relating to monitored prescription drug history reports.
No action taken on February 25, 2025.
Referred to the joint committee for review of Administrative Rules, February 25, 2025.
Relating to transferring Flualprazolam and scheduling four (4) synthetic benzodiazepine substances.
No action taken on February 25, 2025.
Referred to the joint committee for review of Administrative Rules, February 25, 2025.
Relating to scheduling Zuranolone.
No action taken on February 25, 2025.
Referred to the joint committee for review of Administrative Rules, February 25, 2025.
Relating to scheduling nine fentanyl-related substances.
No action taken on February 25, 2025.
Referred to the joint committee for review of Administrative Rules, February 25, 2025.
Relating to mail delivered prescriptions.
No action taken on February 25, 2025.
Referred to the joint committee for review of Administrative Rules, February 25, 2025.
JESSE JAMES
Chairperson
Loading...
Loading...